FORMATO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 10.274
AS - Asia 5.337
EU - Europa 3.331
SA - Sud America 2.912
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 110
OC - Oceania 19
Totale 22.170
Nazione #
US - Stati Uniti d'America 9.972
BR - Brasile 2.592
SG - Singapore 2.061
CN - Cina 1.798
UA - Ucraina 1.122
IT - Italia 744
HK - Hong Kong 459
DE - Germania 417
VN - Vietnam 368
FR - Francia 274
FI - Finlandia 192
SE - Svezia 182
GB - Regno Unito 153
CA - Canada 137
AR - Argentina 115
TR - Turchia 86
IQ - Iraq 77
IN - India 70
BD - Bangladesh 59
ZA - Sudafrica 58
MX - Messico 56
EC - Ecuador 51
RU - Federazione Russa 49
UZ - Uzbekistan 48
VE - Venezuela 46
PK - Pakistan 43
KR - Corea 38
MA - Marocco 34
BE - Belgio 33
CO - Colombia 32
JP - Giappone 25
PL - Polonia 25
ES - Italia 23
ID - Indonesia 21
KE - Kenya 21
CL - Cile 20
CR - Costa Rica 20
NP - Nepal 20
PE - Perù 20
TN - Tunisia 20
GT - Guatemala 19
AU - Australia 18
NL - Olanda 18
AE - Emirati Arabi Uniti 17
EU - Europa 17
PY - Paraguay 16
DZ - Algeria 15
PH - Filippine 15
EG - Egitto 14
JM - Giamaica 14
JO - Giordania 14
KZ - Kazakistan 13
UY - Uruguay 13
DO - Repubblica Dominicana 11
HN - Honduras 11
IL - Israele 11
KG - Kirghizistan 11
LB - Libano 11
AZ - Azerbaigian 10
GR - Grecia 10
OM - Oman 10
AT - Austria 9
CZ - Repubblica Ceca 9
DK - Danimarca 8
SA - Arabia Saudita 8
AL - Albania 7
LT - Lituania 7
NI - Nicaragua 7
PS - Palestinian Territory 7
BG - Bulgaria 6
BO - Bolivia 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
HR - Croazia 5
MY - Malesia 5
SV - El Salvador 5
AO - Angola 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
GE - Georgia 4
IE - Irlanda 4
IR - Iran 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
CG - Congo 3
CH - Svizzera 3
ET - Etiopia 3
LU - Lussemburgo 3
MD - Moldavia 3
PA - Panama 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
Totale 22.049
Città #
Dallas 2.500
Singapore 1.101
Chandler 1.029
Jacksonville 687
San Jose 664
Ashburn 631
Hong Kong 456
Council Bluffs 363
Princeton 356
Beijing 328
Nanjing 294
Santa Clara 257
New York 222
São Paulo 209
Columbus 207
Dearborn 172
Lauterbourg 165
Wilmington 148
Sassari 145
Nanchang 134
Ho Chi Minh City 129
Los Angeles 117
Shanghai 112
Ann Arbor 102
Milan 100
Boardman 99
Hanoi 85
Shenyang 85
Rio de Janeiro 78
Tianjin 72
Hebei 71
Changsha 68
Belo Horizonte 67
Jiaxing 47
Woodbridge 46
Tashkent 44
Campinas 42
Buffalo 41
Curitiba 41
Andover 39
Jinan 39
Orem 38
San Francisco 38
Seoul 38
Zhengzhou 37
Toronto 36
Baghdad 35
Brasília 35
Ningbo 34
Porto Alegre 34
Brussels 33
Johannesburg 33
Mountain View 32
Kunming 31
Miano 31
Atlanta 29
Izmir 29
Cagliari 28
Hangzhou 28
Phoenix 28
Brooklyn 27
Montreal 26
Rome 25
Salvador 25
Norwalk 24
Tokyo 24
Warsaw 24
Denver 23
Guarulhos 22
Ribeirão Preto 22
Chicago 21
Guangzhou 21
Haiphong 21
London 20
Florence 19
Fortaleza 19
Goiânia 19
Manaus 19
Nairobi 19
Boston 18
Quito 18
Sorocaba 18
Frankfurt am Main 17
Helsinki 17
Santo André 17
Campo Grande 16
Da Nang 16
Guayaquil 16
Juiz de Fora 16
Manchester 16
Osasco 16
Chennai 15
Dhaka 15
Mumbai 15
Recife 15
Santiago 15
São José dos Campos 15
Taizhou 15
Guatemala City 14
Houston 14
Totale 12.973
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 253
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 221
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 213
Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection 207
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 206
A study of the switch of fetal hemoglobin in newborn erythrocytes fractionated by density gradient 204
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 202
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 196
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 193
Apolipoprotein Profiles in Atherosclerotic Disease 190
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 185
Apolipoprotein profiles in atherosclerotic disease 181
A study of the switch of fetal hemoglobin in newborn erytrocytes fractionated by density gradient. 179
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 176
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 172
Biodiversità marina della Sardegna: prospettive di valorizzazione e sfruttamento sostenibile dei poriferi 170
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 169
A reversed phase HPLC method for the simultaneous determination of all monosaccharides contained in galactosaminoglycan isomers from human aorta proteoglycans 169
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 169
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 166
Morfogenesi cronica dei poriferi: la strutturazione della matrice extracellulare è modulata dai glicosaminoglicani? 165
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 163
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 162
Apolipoprotein Profiles in Atherosclerotic Disease 162
Differential proteomic analysis of human atherosclerotic plaque extracts 157
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 154
Apolipoprotein profiles in atherosclerotic disease 154
Distribution of low - density lipoprotein-bound low molecular weight thiols: a new analytical approach 152
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. IF 2000: 2.071 JCR: Q1 151
Buoyant density of Lp(a) subclasses in hypercholesterolemia 150
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 150
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 149
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 147
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 146
Adhesion properties and proteoglycans produced by subsequent subcultures of rat fibroblasts with different contact inhibition 145
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 145
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 144
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 144
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 143
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 142
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 142
Diagnosi neonatale delle emoglobinopatie mediante isoelettrofocusing delle Emoglobine 141
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 140
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 140
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 140
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 140
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 137
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 136
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 134
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 133
A comparative study of the insolubilization of low density lipoproteins by two different families of aortic proteoglycans 132
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 132
Cellular adhesion of rat hepatocytes during the last phase of the phenotype differentiation 131
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 130
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 129
Sulphated polysaccharide content and localization in some marine sponge species. 129
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 129
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 127
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 124
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 123
Determination of galactosaminoglycan disaccharides by high performance capillary electrophoresis: applications to analysis of human aorta proteoglycans 123
Identification and characterization of biomarkers in atherosclerosis and diabetes. 123
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 123
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 121
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 121
The role of GAGs in cell to cell adhesion of rat fibroblasts: a preliminary investigation 121
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 120
Hb Hamilton [beta11(A8)Val->Ile] in Sardinia. 120
Hemoglobin Hamilton [β11(A8)Val→Ile] in Sardinia 120
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics 119
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 119
Urine bikunin as a marker of renal impairment in Fabry's disease 119
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 119
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 119
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 118
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques 116
Glycosamynoglycan diversity in sponge extracellular matrix 116
IDENTIFICATION, QUANTIFICATION AND STRUCTURAL CHARACTERIZATION OF GLYCOSAMINOGLYCANS FROM PORCINE AORTIC VALVE TISSUE 116
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. IF 2000: 7.368 JCR: Q1 114
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 114
Estrogen receptors in the liver of intact and gonadectomized rats: determination by hydroxylapatite assay 114
GAG and protein composition of GAG-protein complexes from normal human plasma 113
Factors affecting S-homocysteinylation of LDL apoprotein B 113
Cryopreservation of porcine aortic valve: open status of the aortic leaflets results in increased matrix glycosaminoglycan structural maintenance 112
Atherosclerotic modifications of human proteoglycans 112
Role of the small proteoglycan bikunin in human reproduction 112
Lipoprotein(a) and the arterial wall 111
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 111
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 111
Protein oxidation in unstable plaque extracts from human carotid segments 110
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 110
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 110
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 110
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 109
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 108
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 107
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 107
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 107
Chromatin microfluorometry and energy status of primary cultures of adult rat hepatocytes: Effects of testosterone and dexamethasone 106
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 105
Totale 14.094
Categoria #
all - tutte 89.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022719 0 0 0 16 10 3 54 52 94 36 95 359
2022/20231.916 188 124 37 324 236 306 0 230 328 19 81 43
2023/2024594 93 41 15 16 133 102 6 32 9 12 76 59
2024/20255.069 32 40 310 56 212 122 320 881 1.955 768 263 110
2025/20267.152 276 1.731 1.126 1.000 680 459 831 273 332 285 106 53
2026/20272.456 138 631 796 891 0 0 0 0 0 0 0 0
Totale 22.170